Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents

Diabetes Care

Volumn 31, Issue 4, 2008, Pages 770-775

  Velásquez Mieyer, Pedro A ^a,d   Cowan, Patricia A ^a   Pérez Faustinelli, Sylvia ^a   Nieto Martínez, Ramfis ^b   Villegas Barreto, Cesar ^a   Tolley, Elizabeth A ^a   Lustig, Robert H ^c   Alpert, Bruce S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

^d LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AREA UNDER THE CURVE; ARTICLE; B LYMPHOCYTE ACTIVATION; CAUCASIAN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; ETHNICITY; FEMALE; GROUPS BY AGE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; RACE DIFFERENCE; SCHOOL CHILD; BLOOD; BLOOD PRESSURE; HYPERTENSION; METABOLISM; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHILD; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MALE; OBESITY;

EID: 48649110492     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1525     Document Type: Article

References (35)

1. Velasquez-Mieyer PA, Perez-Faustillini S, Cowan PA: Identifying children at risk for obesity, type 2 diabetes, and cardiovascular disease. Diabet Spectr 18:213-220, 2005 2. Dagogo-Jack S: Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc 95: 774, 779-789, 2003
2. Gower BA, Granger WM, Franklin F, Shewchuk RM, Goran MI: Contribution of insulin secretion and clearance to glucose-induced insulin concentration in African-American and Caucasian children. J Clin Endocrinol Metab 87:2218-2224, 2002
3. Osei K, Schuster DP: Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med 11:755-762, 1994
4. Haffner SM: The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3A- 11A, 2006
5. Kalra L, Rambaran C, Chowienczyk P, Goss D, Hambleton I, Ritter J, Shah A, Wilks R, Forrester T: Ethnic differences in arterial responses and inflammatory markers in Afro-Caribbean and Caucasian subjects. Arterioscler Thromb Vasc Biol 25:2362-2367, 2005
6. Drucker DJ: Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26:2929-2940, 2003
7. Velasquez-Mieyer PA, Cowan PA, Umpierrez GE, Lustig RH, Cashion AK, Burghen GA: Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects.
8. Int J Obes Relat Metab Disord 27:1359-1364, 2003
9. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301, 2000
10. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculations with Computer Programs. New York, Springer-Verlag, 1986, p. 77-81
11. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 30:S42-47S, 2007
12. Kadish AH, Little RH, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-119, 1968
13. LabCorp: Directory of Services and Interpretive Guide. Burlington, NC, LabCorp, 2001
14. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, Tracy R, Jacobs DR Jr: Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 111:1985-1991, 2005
15. Patel DA, Srinivasan SR, Xu JH, Li S, Chen W, Berenson GS: Distribution and metabolic syndrome correlates of plasma C-re- active protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metabolism 55:699-705, 2006
16. Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM: Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53:1773-1781, 2004
17. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830, 2003
18. Korner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W: New predictors of the metabolic syndrome in children-role of adipocytokines. Pediatr Res 2007
19. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556, 2004
20. Ku CY, Gower BA, Hunter GR, Goran MI: Racial differences in insulin secretion and sensitivity in prepubertal children: role of physical fitness and physical activity. Obes Res 8:506-515, 2000
21. Uwaifo GI, Nguyen TT, Keil MF, Russell DL, NicholsonJC, Bonat SH, McDuffie JR, Yanovski JA: Differences in insulin secretion and sensitivity of Caucasian and African American prepubertal children. J Pediatr 140:673-680, 2002
22. Velasquez-Mieyer PA, Cowan PA, Perez- Faustillini S, Markee J, Burghen GA: Predicting impaired glucose tolerance in severely obese adolescents. In Proceedings of the International Congress on Endocrinology, 2004, p. 1433-1437
23. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP: Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 153: 242-250, 2001
24. Wessel J, Moratorio G, Rao F, Mahata M, Zhang L, Greene W, Rana BK, Kennedy BP, Khandrika S, Huang P, Lillie EO, Shih PA, Smith DW, Wen G, Hamilton BA, Ziegler MG, Witztum JL, Schork NJ, Schmid-Schonbein GW, O'Connor DT: C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/ β- adrenergic pathway loci. J Hypertens 25: 329-343, 2007
25. Lange LA, Burdon K, Langefeld CD, Liu Y, Beck SR, Rich SS, Freedman BI, Brosnihan KB, Herrington DM, Wagenknecht LE, Bowden DW: Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study. Ann Hum Genet 70:717-725, 2006
26. Perfetti R, Zhou J, Doyle ME, Egan JM: Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum ho- meobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 141:4600-4605, 2000
27. Rask E, Olsson T, Soderberg S, Johnson O, Seckl J, Holst JJ, Ahren B: Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 24:1640-1645, 2001
28. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB, Olivan B: Incretin levels and effect are markedly enhanced one month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30:1709 - 1716, 2007
29. Adam TC, Lejeune MP, Westerterp-Plan- tenga MS: Nutrient-stimulated glucagon- like peptide 1 release after body-weight loss and weight maintenance in human subjects. Br J Nutr 95:160-167, 2006
30. Bryer-Ash M, Cheung A, Pederson RA: Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats. Regul Pept 51:101-109, 1994
31. Sirinek KR, Pace WG, Crockett SE, O'Dorisio TM, Mazzaferri EL, Cataland S: Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion. Am J Surg 135:151-155, 1978
32. Steinberg GR: Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 6:888 -894, 2007
33. Mentlein R: Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85:9-24, 1999
34. Ahren B, Hughes TE: Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice. Endocrinology 146:2055-2059, 2005
35. Ruiz P, Zacharievich N, Hao L, Viciana AL, Shenkin M: Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny. Clin Immunol Immunopathol 88:156-168, 1998